Melissa Ann LoPresti*, Neuro+Digital Initiative, Department of Neurosurgery, Columbia University Medical Center, New York, NY USA, New York, United States Mickey Abraham, Neuro+Digital Initiative, Department of Neurosurgery, Columbia University Medical Center, New York, NY USA, New York, United States Olivier Bruyère, Department of Public Health, Epidemiology and Health Economics, ULg, Liège, Belgium, Liege, Belgium Justin Slomian, Department of Public Health, Epidemiology and Health Economics, ULg, Liège, Belgium, Liege, Belgium Jean-Yves Reginster, Department of Public Health, Epidemiology and Health Economics, ULg, Liège, Belgium, Liege, Belgium Geoff Appelboom, Neuro+Digital Initiative, Department of Neurosurgery, Columbia University Medical Center, New York, NY USA, New York, United States E. Sander Connolly, Neuro+Digital Initiative, Department of Neurosurgery, Columbia University Medical Center, New York, NY USA, New York, United States Track: Research Presentation Topic: Mobile & Tablet Health Applications Presentation Type: Poster presentation Submission Type: Single Presentation Last modified: 2014-05-16

If you are the presenter of this abstract (or if you cite this abstract in a talk or on a poster), please show the QR code in your slide or poster (QR code contains this URL).

Background: Mobile health (mHealth) is a growing sector of technology used in clinical practice. With the ubiquity of this technology in today's society, the promise it holds for use in medicine is vast.

Purpose: To conduct a systematic review examining the current research and clinical trials involving mobile health applications used by human participants worldwide.

Design: We searched the clinicaltrials.gov database for all original trials examining mobile health applications role and use internationally and in varying clinical settings.

Results: Fifty trials were included. Eighty-eight percent of included trials were initiated from 2012 to 2014, with only 20% of all included trials currently completed. The overwhelming majority of trials originated from the United States (57%) and western/European countries (29%). There was a broad distribution of the trials in regards to study focus and purpose, involving application in behavior change (25%), treatment adherence (8%), disease management (47%), and patient-reported outcomes (20%). Most included trials were performed in the setting of chronic diseases.

Conclusion: The use of mHealth is a growing field with broad implications and indications in clinical practice. This trend of increasing trials, studies, and pervasiveness of technology in health care is a more recent development. Evidence in support of this technology is unclear from the trials included in this study; however, the significance of mobile health applications, devices, and technology most assuredly have a role in chronic disease management and work to improve patient engagement.